FRAQOL: Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary

Sponsor
Jeanne et Leon Developpement (Other)
Overall Status
Recruiting
CT.gov ID
NCT05659706
Collaborator
Gerontopôle des Pays de la Loire (Other)
60
1
18
3.3

Study Details

Study Description

Brief Summary

The management of frailty is a difficulty in the Temporary Accommodation Residences. Frailty represents a risk of reducing the activities of the elderly person. Jeanne & Léon Développement® offers an activity program that integrates several dimensions (physical and/or nutritional and/or social and/or psychological). To obtain the expected benefit, effect of the Jeanne & Léon® activities program on the residents's frailty and quality of life in temporary accommodation, the activity of at least one of these approaches is used as a global stimulant and thus activates the remaining skills to help fight against the frailty syndrome. In order to do this, the framework of the temporary accommodation, the group dynamics and the presence of a professional facilitator ensure the conditions for adherence to the program and promote the realization of stimulating activities.

The phenomenon of activation initiated during the residential activity program can lead to an improvement in the components of frailty which is maintained over time. This will be assessed in terms of the occurrence of events after the activity program has been followed.

Condition or Disease Intervention/Treatment Phase
  • Other: cognitive evaluations and non cognitive evaluations

Detailed Description

The clinical assessment will be performed by the investigating physician.

Initial follow-up: Fragility and Quality of Life assessment is carried out by the trained nursing staff (doctor, nurse) of the Résidence Les Tamaris. The clinical assessment will include screening for thymic disorders. All experimenters will be specifically trained in the protocol and GCP beforehand.

V0 (inclusion visit carried out within 72 hours after admission to the residence): inclusion after information and non-opposition, then randomization into the control group or the intervention group V1 (initial assessment visit performed within 96 hours after admission to the residence): initial assessment of the resident V2 (V1+ 21 days +/- 1 day: end of main study visit): final evaluation of the main study.

In case of discharge from the Residence: validation of the contact information and the follow-up telephone schedule of the participant.

Post-program follow-up: identification of intercurrent events by the Residence staff

VS1 (V2 + 1 Month), SV2 (V2 + 3 Months): interview of participants by on-site follow-up or telephone call VS3 (V2 + 6 Months): on-site follow-up or final phone call.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary
Actual Study Start Date :
Oct 20, 2022
Anticipated Primary Completion Date :
Jan 20, 2024
Anticipated Study Completion Date :
Apr 20, 2024

Arms and Interventions

Arm Intervention/Treatment
Arm 1: "intervention" group, named "Group 3+"

attend at least three workshops per week

Other: cognitive evaluations and non cognitive evaluations
Mini Mental State Examination Charlson Comorbidity Index Katz Index ICOPE step 1 The 15-item geriatric depression scale (GDS-15) Medical Outcomes Study Short Form 36 (SF-36) Short Physical Performance Battery ( SPPB)

Arm 2: "control" group, named "Group 0-1"

not participate in the activities program or will attend a maximum of one workshop per week.

Other: cognitive evaluations and non cognitive evaluations
Mini Mental State Examination Charlson Comorbidity Index Katz Index ICOPE step 1 The 15-item geriatric depression scale (GDS-15) Medical Outcomes Study Short Form 36 (SF-36) Short Physical Performance Battery ( SPPB)

Outcome Measures

Primary Outcome Measures

  1. The endpoint will be a composite score, the FRAQOL, based on a combination of functional performance assessment (Short Physical Performance Battery (SPPB) composite test) and Quality of Life (Short Form 36 (SF-36) self questionnaire). [8 months]

    The endpoint will be a composite score, the FRAQOL, based on a combination of functional performance assessment (Short Physical Performance Battery (SPPB) composite test) and Quality of Life (Short Form 36 (SF-36) self questionnaire). The Short Physical Performance Battery (SPPB) composite test and Short Form 36 (SF-36) self questionnaire will be assessed within 96 hours of admission to the residence, prior to program implementation, and then 3 weeks after the initial assessment SPPB: minimum value = 0 ; maximum value = 12 SPPB 0-6= Low performance SPPB 7-9 =Intermediate intermédiaires SPPB 10-12 =High performance SF36: minimum value = 0 ; maximum value = 100

Secondary Outcome Measures

  1. Evolution of each item of the scores Short Form 36 self questionnaire [15 months]

    Evolution of each item of the scores Short Form 36 self questionnaire

  2. Evolution of each item of the scores Short Physical Performance Battery (SPPB) composite test [15 months]

    Evolution of each item of the scores Short Physical Performance Battery (SPPB) composite test

  3. Evolution of each item of the Step 1 of ICOPE(Integrated Care for Older People) [15 months]

    Evolution of each item of the Step 1 of ICOPE(Integrated Care for Older People) no scores: answers yes/no to different items

  4. Evolution of intercurrent health events of the composite score FRAQOL at one, three and six months after the end of the program [15 months]

    Evolution of intercurrent health events of the composite score FRAQOL at one, three and six months after the end of the program The objective is to estimate the frequency of occurrence of intercurrent health events of the composite score FRAQOL

  5. Estimation of the incremental cost associated with the occurrence of intercurrent events up to six months after program completion [15 months]

    Estimation of the incremental cost associated with the occurrence of intercurrent events up to six months after program completion

  6. Use of the ICOPE screening questionnaire responses as a descriptive element of the study population and analysis of a potential predictive relationship on the 6-month outcome. [15 months]

    Use of the ICOPE screening questionnaire responses as a descriptive element of the study population and analysis of a potential predictive relationship on the 6-month outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 60 years and over

  • Participant who has been living in temporary accommodation at the Résidence Les Tamaris for a maximum of 72 hours

  • Visual, auditory and oral or written abilities in French sufficient to complete the assessments and participate in the Jeanne & Léon® Program activities

  • Agrees to participate in the study and follow-ups for up to six months after the end of the activity program/temporary residence

  • Non-opposition accompanied by the information note co-signed by the investigator and the resident participating in the study, or the family member or the designated trusted person (if applicable)

  • Must be affiliated to a social security plan

Exclusion Criteria:
  • Refusal to participate by the resident, family member or designated support person

  • Communication difficulties, sensory and/or motor deficits

  • Medical contraindication

  • Participant already included in another research protocol

  • Person under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Résidence les Tamaris- Jeanne et Léon Développement Bois-de-Cené France 85710

Sponsors and Collaborators

  • Jeanne et Leon Developpement
  • Gerontopôle des Pays de la Loire

Investigators

  • Study Director: Gilles BERRUT, Pr, Gérontopôle des Pays de la Loire

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeanne et Leon Developpement
ClinicalTrials.gov Identifier:
NCT05659706
Other Study ID Numbers:
  • 21-S01
First Posted:
Dec 21, 2022
Last Update Posted:
Dec 21, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jeanne et Leon Developpement
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2022